Facilitation of Plasminogen Activation by a Plasmin Substrate Containing a Lysyl Residue

Summary

The plasmin substrate, H-D-norleucyl-hexahydrotyrosyl lysine-p-nitroanilide (Spectrozyme-PL), was found to be equiva lent to 6-aminohexanoate as an enhancer of porcine and human plasminogen activation by urokinase and of removal of the 1-77 peptide of plasminogen by plasmin. Activation of plasminogen lacking kringles 1-4, on the other hand, was not influenced by Spectrozyme PL. Although the rate of activation of human plasminogen and the modification of human plasminogen by plasmin are faster by an order of magnitude than that of the activation and modification of porcine plasminogen, both reactions in the human zymogen, the hydrolysis at arg₅₆₁-val₅₆₂ and at lys₇₇lys₇₈, are accelerated by Spectrozyme PL. The findings indicate that kinetic interpretation of plasminogen activation in solutions containing substrates, where the substrate has been incorporated to inhibit feedback proteolysis by plasmin, must account for the cofactor activity as well as the inhibitory activity of the substrate.

• References

• 1 Bachmann F. Fibrinolysis. In: Thrombosis and Haemostasis. Ver straeteM, Vermylen J, Lijnen R, Arnout J. (eds). Leuven: University Press; 1987: 227-265
• 2 Pannell R, Gurewich V. Pro-urokinase: A study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. Blood 1986; 67: 1215-1223
• 3 Ellis V, Scully MF, Kakkar VV. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes J Biol Chem 1989; 264: 2185-2188
• 4 Violand BN, Byrne R, Castellino FJ. The effect of α-, ω-amino acids on human plasminogen structure and activation. J Biol Chem 1978; 253: 5395-5401
• 5 Collen D, Zamarron C, Lijnen HR, Hoylaerts M. Activation of plasminogen by prourokinase. II. Kinetics. J Biol Chem 1986; 261: 1259-1266
• 6 Takada A, Watahiki Y, Takada Y. Release of N-terminal peptides from glu-plasminogen by plasmin in the presence of fibrin. Thromb Res 1986; 41: 819-827
• 7 Suenson E, Thorsen S. The course and prerequisites of lys-plasmino gen formation during fibrinolysis. Biochemistry 1988; 27: 2435-2443
• 8 Norrman B, Wallén P, Rånby M. Tissue plasminogen activator mediated fibrinolysis: disclosure of a kinetic transition. Eur J Biochem 1985; 149: 193-200
• 9 Hajjar KA, Nachman RL. Endothelial cell-mediated conversion of glu-plasminogen to lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface. J Clin Invest 1988; 82: 1769-1778
• 10 Peterson LC, Brender J, Suensson E. Zymogen-activation kinetics: modulatory effects of trans-4-(aminomethyl)cyclohexane-l-carboxylic acid and poly-D-lysine on plasminogen activation. Biochem J 1985; 225: 149-158
• 11 Pannell R, Gurewich V. Activation of plasminogen by single-chain urokinase or by two-chain urokinase – A demonstration that single chain urokinase has a low catalytic activity. Blood 1987; 69: 022-026
• 12 Machovich R, Litwiller RD, Owen WG. Requirement of zymogen modification for activation of porcine plasminogen. Biochemistry 1992; 31: 11558-11561
• 13 Urano T, de SerranoVS, Chibber BAK, Castellino FJ. The control of the urokinase-catalyzed activation of human glutamic acid 1-plas minogen by positive and negative effectors. J Biol Chem 1987; 262: 15959-15964
• 14 Griffith MJ, Lundblad RL. Dissociation of antithrombin III-thrombin complex. Formation of active and inactive antithrombin III. Biochemistry 1981; 20: 105-110
• 15 Rånby M, Brändström A. Biological control of tissue plasminogen activator-mediated fibrinolysis. Enzyme 1988; 40: 130-143